Johnson & Johnson
Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren’s disease study
14 Nov 2024
Adults with moderately-to-severely active Sjögren’s disease who received investigational FcRn blocker nipocalimab had improvements in disease activity scores at 24 weeks with accompanying significant
Johnson & Johnson MedTech Announces Strategic Agreement with Responsive Arthroscopy to Expand Sports Soft Tissue Solutions
14 Nov 2024
New collaboration to strengthen and deliver advanced soft tissue repair solutions for shoulder, foot and ankle procedures
Why Transparency is Critical for Patients
13 Nov 2024
Johnson & Johnson MedTech Receives IDE Approval for OTTAVA™ Robotic Surgical System
12 Nov 2024
Company prepares to support clinical trial in the United States
Nipocalimab is the first and only investigational therapy granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren’s disease
12 Nov 2024
The Breakthrough Therapy Designation (BTD) for investigational nipocalimab in Sjögren’s disease, a prevalent autoantibody disease with no approved advanced therapies, is supported by results from the
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX
08 Nov 2024
If approved, DARZALEX FASPRO® will become the first treatment option for patients with smoldering multiple myeloma at high-risk of developing multiple myeloma, offering a novel approach to treat befor
Johnson & Johnson MedTech Unveils New Joint Reconstruction Solutions at 2024 AAHKS Annual Meeting
07 Nov 2024
Highlights include the debut of the Solutions in Motion™ initiative aimed at bringing together advanced surgical techniques, innovative implants, and data-driven enabling technologies
Johnson & Johnson MedTech Receives FDA Approval for the VARIPULSE™ Pulsed Field Ablation Platform for the Treatment of Atrial Fibrillation
07 Nov 2024
The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ 3 Electro-anatomical Mapping System, driving efficiency, reproducibility a
Johnson & Johnson advances leadership in rheumatic disease innovation with 43 abstracts at ACR 2024
07 Nov 2024
New data for investigational nipocalimab in Sjögren’s Disease (SjD) and new research on the impact of TREMFYA® (guselkumab) in psoriatic arthritis (PsA) will be highlighted across three oral sessions
Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024
05 Nov 2024
Novel Intravascular Lithotripsy (IVL) catheter demonstrates ability to modify calcium safely, enabling treatment and crossing of tightly-stenosed lower limb lesions Technology has received U.S. FDA cl
Featured
Company story – Quaker Oats
By Kiron Kasbekar | 08 Mar 2024
Quaker Oats is a company whose products I remember from my childhood days. Years before a foreign exchange crisis caused the Indian government to impose curbs on consumer product imports, we used to see a host of foreign brands in the Indian market. Including Quaker Oats, which I remember eating when I was a child, and which has been available for the past two decades or more.
How Quaker Oats grabbed customers’ attention
By Kiron Kasbekar | 07 Mar 2024
Quaker Oats, the American food products giant that was created in 1901 through the merger of many older oat millers, and was acquired by a bigger foods giant, Pepsi, in 2001, has been an innovative company. One example of its innovativeness shows in its packaging – the cereal box it launched in 1915.
Company story – Cunard Line
By Kiron Kasbekar | 12 Jan 2024
The Cunard Line started its life in Glasgow in 1839 as the British and North American Royal Mail Steam-Packet Company when Samuel Cunard was awarded the first British transatlantic steamship mail contract.
Samuel Slater – textile tycoon or traitor?
By Kiron Kasbekar | 26 Dec 2023
Samuel Slater is a name that holds significant importance in the annals of American industrial history. Often referred to as the ‘Father of the American Factory System’, Slater's contributions played a pivotal role in shaping the nation’s industrial landscape.
Underwood Typewriter Company – an icon of the past
By Kiron Kasbekar | 21 Dec 2023
You’ve probably never heard of Underwood typewriters. For the company folded up in 1963 – 60 years ago. You may not even have seen and handled a typewriter, unless someone in your family owned one.
The rise and fall of Chrysler
By Kiron Kasbekar | 16 Dec 2023
A century ago, the American automobile industry was more crowded than a vegetable market on a Sunday morning, with such a wide variety of stuff on sale that buyers were spoilt for choice. Buyers could pick and choose, bargain, pay up and drive out with the newly purchased vehicle.
TRW – the tide turned
By Kiron Kasbekar | 13 Dec 2023
There used to be an American company called Thompson Ramo Wooldridge Inc. This company, which was a global supplier of automotive systems, modules, and components to car and truck manufacturers, started small, as most companies do. Then, as the automotive industry grew bigger, so did TRW.
The rise and fall of Nokia
By Aniket Gupta | 07 Dec 2023
My interest is stories about dominant companies that failed all of a sudden. These companies were once etched into people’s minds but have since become a symbol of nostalgia. One such company, which was the biggest in its industry before it failed catastrophically, is Nokia.
Yahoo!: The first king of the internet
By Aniket Gupta | 01 Dec 2023
The year is 1994. You go to the internet to search for a particular website, but there is no Google that could be used to search your desired website. What do you do? The answer is that you use Yahoo.
.jpg)
